David C. Ott, 10% Owner at Urovant Sciences Ltd. (UROV), bought 9,995 shares at $9.99 ($100K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ROIV | SELL | 2023-06-26 | $257.4M | — | Filing → |
| FLAC | BUY | 2022-11-04 | $17.1M | — | Filing → |
| INBX | BUY | 2022-10-12 | $40.0M | — | Filing → |